New York City will use the company's COVID-19 test in its public school system.
News & Analysis: Fulgent Genetics, Inc.
The Nasdaq Composite failed to hit a record for the first time in a week.
Abbott's announcement of a new 15-minute COVID-19 test threatens recent revenue growth.
FLGT earnings call for the period ending June 30, 2020.
FLGT earnings call for the period ending March 31, 2020.
These three companies are all growing like gangbusters and have already reached profitability.
We take a look at three small and promising healthcare companies across diagnostics, surgical products, and genetic testing.